-
Document de presse | 2024.10.15
Resistance mutations to nirsevimab are rare in respiratory syncytial virus (RSV)
Nirsevimab is an antibody targeting the respiratory syncytial virus (RSV). Available in France since September 2023, it is indicated in neonates and infants for the prevention of bronchiolitis caused by RSV. However, its widespread use raises the question of the emergence of resistance mutations. The POLYRES study, the largest prospective surveillance study of nirsevimab breakthrough infections...
-
Vidéo | 2024.10.09
Virtual reality and artificial intelligence in surgery with Jean-Baptiste Masson
Virtual reality and artificial intelligence at the service of surgery: Jean-Baptiste Masson tells you all about it!These innovative technologies now make it possible to prepare and plan an operation by immersing oneself in a realistic simulation of the patient's medical images.As a result, surgeons can better anticipate the gestures to be performed, and have access to precise data to inform their...
-
Document de presse | 2024.10.23
Pasteur Network members Unite Global Efforts to Accelerate mRNA Vaccine Research
PNAM2024: Pasteur Network members Unite Global Efforts to Accelerate mRNA Vaccine Research through Strategic Memorandum of UnderstandingRio de Janeiro, October 23rd, 2024 – Key members of the Pasteur Network, including Fundação Oswaldo Cruz (Fiocruz), the Institut Pasteur de Dakar, the Institut Pasteur Korea, the Institut Pasteur, and the Institut Pasteur de Tunis, have signed a strategic...
-
Article | 2021.11.29
Antimicrobial Resistance Graduate School (ANTIRES)
The Antimicrobial Resistance Graduate School proposes a structured program of excellence in the fields of Microbiology, Virology, Mycology, Parasitology and Infectious Diseases at both Master and Doctoral levels with a strong involvement of teachers, researchers and physicians.
-
Vidéo | 2024.11.05
How AI revolutionizes virus observation
The Institut Pasteur uses artificial intelligence to transform the observation of cells infected with SARS-CoV-2. Using holotomography microscopy, we obtain impressively clear black-and-white images. AI then analyzes these images and colors each element: nuclei in red, mitochondria in green, and lipids in blue. This innovative technology enables us to monitor, in real time, the...
-
Vidéo | 2024.11.05
Science or Fiction?... Institut Pasteur researchers attending the Utopiales
Science or Fiction ?At the French scientific outreach event "Utopiales", we put the public through a surprising scientific quiz: can we recover dinosaur DNA? Can sponges walk? Can cells be remotely controlled by light? Our scientists from the Institut Pasteur demystify these questions and bring you the answers!Discover the science behind the improbable and test your knowledge! Video in...
-
News | 2024.11.04
A novel method for producing DNA-based therapies
Scientists have combined enzyme and chemical techniques to develop an innovative method for producing synthetic DNA molecules. This novel approach opens up many new possibilities, especially for the production of large molecules that can be used for future therapies.
-
Report | 2022.11.21
Unraveling the brain's mysteries
The brain is the body's conductor, orchestrating a host of vital functions. It is in charge of our language and movements. It is the seat of our consciousness, intelligence and memory and our emotions, thoughts and perceptions. But although our understanding of the brain is improving all the time, in many ways it remains a mystery to us. At the Institut Pasteur, teams are working to understand...
-
Article | 2023.01.20
Epidemiology and Public Health
With sessions on theory and hands-on practicals, the courses held at the Teaching Center are grouped into three themed areas: Epidemiology and Public Health, Mechanisms of Living Organisms, and Biology of Microorganisms.
-
News | 2024.10.16
Fundamentally applied: a new therapeutic target for the treatment of bone marrow cancer
“Fundamentally applied” is the name of our video series with researchers from the Institut Pasteur, whose research work has led to imagining new healthcare products, currently in development. In this new episode, Caroline Demangel, Head of Immunobiology and Therapy Unit at Institut Pasteur, tells how the study of a toxin from a mycobacterium responsible for a tropical disease called Buruli...
